Kim Kuypers

ICPR 2024, 6-8 June > Speakers > Kim Kuypers

Kim Kuypers, Phd

Associate Professor at Maastricht University at the Faculty of Psychology and Neuroscience, The Netherlands

Microdosing psychedelics: Where are we and where to go from here?

Kim Kuypers will speak at ICPR about her recent work on studying microdosing, which has recently gained new attention about research coming out questioning its efficacy.
“I wouldn’t immediately say there is nothing,” Kim Kuypers says, “but we should be very careful about the methodology and should understand what has happened”.

The title of her talk is Microdosing psychedelics: Where are we and where to go from here?


In 2018, Dr. Kuypers was named the Principal Investigator for the Netherlands in the MAPS Phase 2 Clinical Trials of MDMA-Assisted Therapy for PTSD in Europe. Her current research interests are MDMA and psychedelics, and their effects on (social) cognition, creativity, hormones, and underlying brain mechanisms. Dr. Kuyper is an Associate Professor at the Faculty of Psychology and Neuroscience at Maastricht University, The Netherlands. 

Her aim is to understand the neurobiology underlying flexible cognition, empathy, and well-being. Dr. Kuypers and her team employ a psychopharmacological model to study the (sub)acute and longer term effects of psychedelics on these behaviours and their underlying biology. Along with her colleague Prof. Jan Ramaekers, in collaboration with the Beckley Foundation, Dr. Kuypers and the team at Maastricht have been investigating the optimal dose of microdosing LSD to improve mood, cognition and pain resilience, with minimal side effects and interferences to day to day life.

Dr. Kim Kuypers received her MSc in Psychology and Neuropsychology in 2002 and her Ph.D. in Psychology and Psychopharmacology in 2007, both from Maastricht University. For the following four years, she remained in Maastricht conducting postdoctoral research into the effects of MDMA on memory and driving performance. Additionally, in 2011, she was also a postdoctoral researcher at Belgium’s Ghent University where she studied the risk analysis of alcohol and drugs in traffic accidents.

Other Speakers at ICPR 2022

Founder and Executive Director at MAPS, the Multidisciplinary Association for Psychedelic Studies, United States

Psychologist at Johns Hopkins Center for Psychedelic and Consciousness Research, United States

Founder of Fungi Perfecti and CEO of MycoMedica Life Sciences PBC, United States

Ready To Attend ICPR 2022?​

Join the leading conference in Europe dedicated to advancing psychedelic research and therapies.

About ICPR

The Interdisciplinary Conference on Psychedelic Research (ICPR) is Europe’s leading academic conference dedicated to advancing psychedelic research and therapies organised by the OPEN Foundation since 2010. ICPR is a biennial conference focused on high-quality scientific and scholarly research into psychedelics. ICPR 2022 is our fifth event. After our hugely successful online conference in 2020, we are returning to the prestigious Philharmonie Theatre for an in-person event! ICPR will take place in Haarlem (next to Amsterdam) from September 22nd to 24th, 2022.